Analyst Ratings for RXO, Inc. (rxo)
rxo Rating Summary
rxo Price Target Summary
- Highest: $35.00 (BMO Capital)
- Lowest: $13.00 (JPMorgan)
- Average: $22.57
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$22.57 (-0.4%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
Percentile Rank: 30%
Rating Score: 3.3 / 10
Percentile Rank: 30%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/7/2026 | Citizens | Jeff Kauffman | Upgrade | Market Outperform (Market Perform) |
30.00 (N/A) |
21.00 (22.66) |
7.9% | Details |
| 7/28/2026 | TD Cowen » Updated 8/7/2026 |
Jason Seidl | Downgrade | Sell (Hold) |
17.50 (19.00) |
24.11 (22.66) |
-6.01% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
